Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CBAY | BBIO | BHC | ||
Company | Cymabay Therapeutics | Bridgebio Pharma Inc | Bausch Health Companies Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | ||
Open | 32.49 | 25.12 | 8.76 | ||
High | 32.50 | 25.64 | 8.87 | ||
Low | 32.48 | 25.01 | 8.74 | ||
Last | 32.48 | 25.27 | 8.81 | ||
Change | +0.01 | +0.39 | +0.10 | ||
% Change | +0.03% | +1.57% | +1.15% | ||
Volume | 8,356,200 | 575,347 | 1,082,918 | ||
20-Day Average Volume | 3,390,805 | 1,532,207 | 3,839,156 | ||
Previous Close | 32.47 | 24.88 | 8.71 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 32.35 | 26.46 | 9.07 | ||
20-Day Raw Stochastic | 94.12% | 25.89% | 15.00% | ||
20-Day Relative Strength | 78.00% | 38.92% | 46.50% | ||
Weighted Alpha | +247.60 | -1.32 | +21.98 | ||
Today's Opinion | 100% Buy | 88% Sell | 40% Buy | ||
Previous Opinion | 100% Buy | 88% Sell | 40% Buy | ||
Last Month's Opinion | 100% Buy | 24% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.03% since 03/14/24 | +0.86% since 04/22/24 | +4.44% since 04/22/24 | ||
Low | 32.44 on 03/15/24 | 23.68 on 04/25/24 | 8.43 on 04/23/24 | ||
High | 32.50 on 03/21/24 | 26.26 on 04/23/24 | 8.87 on 04/29/24 | ||
1-Month | |||||
%Chg | +0.90% since 02/21/24 | -18.22% since 03/28/24 | -16.82% since 03/28/24 | ||
Low | 32.15 on 02/22/24 | 23.68 on 04/25/24 | 8.36 on 04/11/24 | ||
High | 32.50 on 03/21/24 | 31.00 on 04/01/24 | 11.46 on 04/03/24 | ||
3-Month | |||||
%Chg | +46.17% since 12/21/23 | -33.18% since 01/29/24 | +5.94% since 01/29/24 | ||
Low | 22.11 on 01/26/24 | 23.68 on 04/25/24 | 7.68 on 02/05/24 | ||
High | 32.50 on 03/21/24 | 41.04 on 02/15/24 | 11.46 on 04/03/24 | ||
6-Month | |||||
%Chg | +122.47% since 09/21/23 | +3.46% since 10/27/23 | +34.32% since 10/27/23 | ||
Low | 12.32 on 10/13/23 | 23.68 on 04/25/24 | 6.53 on 11/13/23 | ||
High | 32.50 on 03/21/24 | 44.32 on 12/28/23 | 11.46 on 04/03/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 3,726,235 | 4,374,700 | 3,182,739 | ||
Shares Outstanding, K | 114,724 | 175,832 | 365,412 | ||
Annual Sales | 31,070,000 | 9,300,000 | 8,757,000,000 | ||
Annual Net Income | -105,370,000 | -643,200,000 | -592,000,000 | ||
Last Quarter Sales | 60,000 | 1,750,000 | 2,408,000,000 | ||
Last Quarter Net Income | -41,900,000 | -168,150,000 | -39,000,000 | ||
60-Month Beta | 0.32 | 1.03 | 0.85 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.35 on 02/28/24 | -0.96 on 02/22/24 | 1.15 on 02/22/24 | ||
Latest Earnings Date | 03/21/24 | 05/02/24 | 05/02/24 | ||
Most Recent Dividend | N/A | N/A | 1.000 on 11/10/10 | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 2.46 |